Los Angeles Capital Management’s ACELYRIN SLRN Stock Holding History

Los Angeles Capital Management’s Portfolio SLRN Stock Details SLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-109,612	Closed	-$271K	–	1445
2025 Q1	$271K	Sell	109,612 -12,391	-10%	-$29.5K	﹤0.01%	929
2024 Q4	$383K	Sell	122,003 -20,690	-14%	-$100K	﹤0.01%	876
2024 Q3	$703K	Sell	142,693 -14,400	-9%	-$74.3K	﹤0.01%	768
2024 Q2	$693K	Buy	+157,093	New	+$736K	﹤0.01%	767

Other funds holding SLRN

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Los Angeles Capital Management's SLRN Position: Q2 2025 in Review

Los Angeles Capital Management sold out of ACELYRIN (SLRN) in Q2 2025, closing a stake of 109,612 shares — an estimated $271K sold.

Los Angeles Capital Management first reported a position in SLRN in Q2 2024 and held it in 4 quarters. The position peaked at $703K in Q3 2024. 2 funds tracked by Wall St. Rank hold SLRN as of Q2 2025.

Los Angeles Capital Management reported no remaining ACELYRIN position as of Q2 2025 after selling out during the quarter.
Los Angeles Capital Management sold 109,612 ACELYRIN shares in Q2 2025, an estimated $271K.
Los Angeles Capital Management first reported a position in ACELYRIN in Q2 2024 and held it in 4 quarters.
Los Angeles Capital Management's ACELYRIN position peaked at $703K in Q3 2024.
2 funds tracked by Wall St. Rank held ACELYRIN as of Q2 2025.

Based on Los Angeles Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.